Cargando…

Is it time to revise the classification of geographical distribution of multiple sclerosis?

Detalles Bibliográficos
Autores principales:	Sahraian, Mohammad Ali, Pakdaman, Hossein, Harandi, Ali Amini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2012
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829246/ https://www.ncbi.nlm.nih.gov/pubmed/24250867

Ejemplares similares

Vitamin D and multiple sclerosis
por: Harandi, Asghar Amini, et al.
Publicado: (2014)

New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice
por: Sahraian, Mohammad Ali, et al.
Publicado: (2012)

Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis
por: Gharagozli, Kurosh, et al.
Publicado: (2012)

The prevalence of multiple sclerosis in Tehran, Iran, in 2020
por: Eskandarieh, Sharareh, et al.
Publicado: (2023)

Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
por: Baghizadeh, Somayyeh, et al.
Publicado: (2016)

Increasing Incidence and Male to Female Sex Ratio of Multiple Sclerosis in Tehran, Iran: A Population-Based Study
por: Kamali, Hoda, et al.
Publicado: (2022)

Association of serum 25(OH) vitamin D(3) concentration with severity of multiple sclerosis
por: Harandi, Ali Amini, et al.
Publicado: (2012)

Significant Increase in the Prevalence of Multiple Sclerosis in Iran in 2011
por: Izadi, Sadegh, et al.
Publicado: (2014)

The first attack of multiple sclerosis presented immediately after voluntary and intensive weight loss: A case series
por: Bitarafan, Sama, et al.
Publicado: (2017)

Reply to Urbanization Theory for Growing Trend of Multiple Sclerosis Letter
por: DEHGHANI, Rouhullah, et al.
Publicado: (2017)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The relation between genital wart and multiple sclerosis
por: Aghaei, Maryam, et al.
Publicado: (2017)

Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series
por: Amini, Payam, et al.
Publicado: (2021)

Historical Issues of Optic neuritis and Sensory Disorder in Persian Traditional Medicine
por: PARVIZ, Mohsen, et al.
Publicado: (2013)

Revision of Prasad's social classification and provision of an online tool for real-time updating
por: Sharma, Rahul
Publicado: (2013)

MLC601 in vascular dementia: an efficacy and safety pilot study
por: Pakdaman, Hossein, et al.
Publicado: (2017)

Persian version of frontal assessment battery: Correlations with formal measures of executive functioning and providing normative data for Persian population
por: Asaadi, Sina, et al.
Publicado: (2016)

Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
por: Molazadeh, Negar, et al.
Publicado: (2023)

Myasthenia Gravis Development and Crisis Subsequent to Multiple Sclerosis
por: Gharagozli, Kurosh, et al.
Publicado: (2011)

Venous Thrombosis in Multiple Sclerosis Patients after High-Dose Intravenous Methylprednisolone: The Preventive Effect of Enoxaparin
por: Kalanie, Hossein, et al.
Publicado: (2011)

Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis
por: Harirchian, Mohammad Hossein, et al.
Publicado: (2014)

Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences
por: Jafari Khaljiri, Helia, et al.
Publicado: (2021)

Distributions of susceptibility loci of Parkinson's disease and multiple sclerosis on human chromosomes
por: Saadat, Mostafa
Publicado: (2014)

Aggressive multiple sclerosis: a matter of measurement and timing
por: Ellenberger, David, et al.
Publicado: (2020)

Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study
por: Pakdaman, Hossein, et al.
Publicado: (2018)

Blood Concentrations of Cadmium and Lead in Multiple Sclerosis Patients from Iran
por: Aliomrani, Mehdi, et al.
Publicado: (2016)

Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: A systematic review
por: Maroufi, Hossein, et al.
Publicado: (2021)

Medical history risk factors in primary progressive multiple sclerosis: A case-control study
por: Maroufi, Hossein, et al.
Publicado: (2021)

Determinants of sexual dysfunction in women with multiple sclerosis
por: Mohammadi, Khadijeh, et al.
Publicado: (2013)

Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran
por: ESKANDARIEH, Sharareh, et al.
Publicado: (2017)

Translation and validation of the Persian version of Godin Leisure-Time Exercise Questionnaire in patients with multiple sclerosis
por: Fattahi, Mohammad-Reza, et al.
Publicado: (2021)

MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study
por: Pakdaman, Hossein, et al.
Publicado: (2023)

Clinical and demographic factors affecting disease severity in patients with multiple sclerosis
por: Baghizadeh, Somayeh, et al.
Publicado: (2013)

Acute attack in a patient with multiple sclerosis 2 days after COVID vaccination: a case report
por: Seyed Ahadi, Maral, et al.
Publicado: (2021)

Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
por: Malekzadeh, Masoud Mohammad, et al.
Publicado: (2020)

Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran
por: Omrani, Mohammad Amin, et al.
Publicado: (2023)

Occurrence of Massively Enlarged Multiple Hydatid Cysts in the Lung and Liver of a Pediatric Patient in Pakistan
por: Khan, Huma, et al.
Publicado: (2021)

Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Vitamin D(3) Concentration Correlates with the Severity of Multiple Sclerosis
por: Shahbeigi, Saeed, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eikak90022qloqaqoinp6n7ci5